Increased MMP-9 expression and activity by aortic smooth muscle cells after nitric oxide synthase inhibition is

Brian S Knipp1, Gorav Ailawadi, John W Ford

  • 1Jobst Vascular Research Laboratories, Section of Vascular Surgery, Ann Arbor, Michigan 48109-0329, USA. riversu@umich.edu

Abstract

Insights

Inhibiting inducible nitric oxide synthase (iNOS) in rat aortic smooth muscle cells increases matrix metalloproteinase 9 (MMP-9) expression and activity. This occurs via activation of nuclear factor-kappaB and activator protein-1 pathways, potentially leading to vessel wall damage.

Area of Science:

  • Vascular Biology
  • Molecular Medicine
  • Biochemistry

Background:

  • Inducible nitric oxide synthase (iNOS) plays a role in vascular homeostasis.
  • Matrix metalloproteinase 9 (MMP-9) is implicated in vascular remodeling and disease.
  • Understanding the interplay between iNOS and MMP-9 is crucial for cardiovascular research.

Purpose of the Study:

  • To elucidate the mechanism by which inhibiting iNOS in rat aortic smooth muscle cells (RA-SMC) leads to increased MMP-9 expression and activity.
  • To investigate the downstream signaling pathways involved in this process.

Main Methods:

  • Rat aortic smooth muscle cells (RA-SMC) were stimulated with interleukin-1beta.
  • iNOS was inhibited using aminoguanidine.
  • MMP-9 activity, protein, and mRNA levels were assessed using gelatin zymography, Western blot, and RT-PCR, respectively.
  • NF-kappaB and AP-1 activation were measured by electrophoretic mobility shift assay.

Main Results:

  • Aminoguanidine treatment significantly increased MMP-9 activity, pro-MMP-9 protein, and MMP-9 mRNA levels in stimulated RA-SMC.
  • Inhibition of iNOS led to decreased cytosolic IkappaB levels, indicating activation of the NF-kappaB pathway.
  • NF-kappaB and AP-1 binding activity were significantly increased following aminoguanidine administration.
  • No significant changes in MMP-2 or TIMP-1 were observed.

Conclusions:

  • iNOS inhibition in cytokine-stimulated RA-SMCs upregulates MMP-9 expression and activity.
  • This upregulation is associated with the activation of NF-kappaB and AP-1 signaling pathways.
  • Disruptions in iNOS function may promote MMP-9-mediated vascular damage through inflammatory cascades.

Related Concept Videos

Nitric Oxide Signaling Pathway01:28

Nitric Oxide Signaling Pathway

Nitric oxide (NO), an inorganic gas, acts as a potent second messenger in most animal and plant tissues. NO diffuses out of the cells that produce it and enters the neighboring cells to generate a downstream response. NO synthase (NOS) catalyzes NO production by the deamination of the amino acid arginine. There are three isoforms of NOS. Endothelial cells have endothelial NOS (eNOS), nerve and muscle cells have neuronal NOS (nNOS), and macrophages produce inducible NOS (iNOS) upon exposure to...
Role of Matrix Metalloproteases in Degradation of ECM01:23

Role of Matrix Metalloproteases in Degradation of ECM

Matrix metalloproteases (MMPs) are enzymes involved in the hydrolysis of proteins and glycoproteins of the extracellular matrix. MMPs are essential for the migration and proliferation of cells through the dense matrix network, throughout embryonic development, and throughout morphogenesis. The first MMP activity discovered was a collagenase in a tadpole's tail undergoing metamorphosis. The active collagen deposition and modifications lead to the morphogenesis of tadpoles into the adult body.
A...
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...